ABBOTT GMBH ARCHITECT CA19-9XR REAGENT KIT; SYSTEM, TEST, CARBOHYDRATE AG (CA19-9), FOR MONIT AND MGMT OF PANCREATIC CANCER
|
Back to Search Results |
|
Catalog Number 02K91-24 |
Device Problem
Low Test Results (2458)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/21/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Patient identifier: multiple sids for one patient = (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer observed falsely depressed architect ca19-9xr results for one patient.The following data was provided: on (b)(6) 2021, sid (b)(6), initial ca 19-9xr result was 156.89 u/ml, repeated >1200 u/ml, automatically diluted to 1:10 with a result of 10366 u/ml.On (b)(6) 2021, (same sample with new sid) sid (b)(6), initial result >1200 u/ml.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
A ticket search by lot indicates that the reagent lot performs as expected for this product.Return testing was not completed as returns were not available.Trending review did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with lot 23013m800 and the complaint issue.Historical performance of reagent lot 23013m800 was evaluated using worldwide data for the architect ca 19-9xr assay.The patient¿s data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot 23013m800 is within the established control limits.Therefore, no unusual reagent lot performance was identified for 23013m800.Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency of the architect ca 19-9xr reagent lot 23013m800 was identified.
|
|
Search Alerts/Recalls
|
|
|